| # | Drug | Count |
|---|---|---|
| 0 | FARICIMAB | 2 |
| 1 | BEVACIZUMAB | 1 |
| 2 | BIMATOPROST | 1 |
| 3 | CYCLOSPORINE | 1 |
| 4 | DUPILUMAB | 1 |
| 5 | HUMAN IMMUNOGLOBULIN G | 1 |
| 6 | INSULIN DEGLUDEC | 1 |
| 7 | INSULIN GLARGINE | 1 |
| 8 | LACOSAMIDE | 1 |
| 9 | OFATUMUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FARICIMAB | 2 | 0.0002 |
| 1 | HUMAN IMMUNOGLOBULIN G | 1 | 0.0000 |
| 2 | INSULIN DEGLUDEC | 1 | 0.0000 |
| 3 | TRAMETINIB | 1 | 0.0000 |
| 4 | BIMATOPROST | 1 | 0.0000 |
| 5 | OFATUMUMAB | 1 | 0.0000 |
| 6 | LACOSAMIDE | 1 | 0.0000 |
| 7 | ORAL SEMAGLUTIDE | 1 | 0.0000 |
| 8 | VEDOLIZUMAB | 1 | 0.0000 |
| 9 | CYCLOSPORINE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 1 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 2 | Prostaglandin Analog [EPC] | 1 | 0.0000 |
| 3 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Insulin Analog [EPC] | 2 | 0.0000 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 7 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1 | 0.0000 |